NEW YORK, Sep 27, 2022 (GLOBE NEWSWIRE) – Reportlinker.com announces the release of the report “Neurosurgery Neurosurgery Robots Market Forecast to 2028 – Impact of COVID-19 and Global Analysis by Components” [Equipment/System, Accessories, and Services]Request [Spinal and Cranial ]type of surgery and users” – https://www.reportlinker.com/p06321058/?utm_source=GNW
However, the high installation costs of neurosurgical robots are hampering the growth of the overall market.
Robots are becoming a reality in many surgical fields, and their popularity is rapidly increasing, and much of this popularity stems from a desire to provide patients with the most minimally invasive surgery options available because minimally invasive surgery is associated with fewer complications, shorter hospital stays, and improved cosmetic outcomes.
Over the past 20 years, neurosurgery robots have increasingly aided in neurosurgery procedures, and in recent years, neurosurgery robots have been developed to perform various procedures.
The general demand is to inform the direction of neurosurgery and put more pressure on neurosurgeons to use neurosurgical robots. The increasing diversity and sophistication of neurosurgical robots has come under ethical scrutiny due to surgical complications that may arise as well as the role of robots in the future.
Brain and spine surgeries require a high degree of technical proficiency, and robotic systems may play a critical role in achieving the desired results. Neurosurgery robots have many advantages, including increased accuracy, better outcomes, quicker recovery, and short hospital stay.
Minimally invasive robotic neurosurgery or minimally invasive robotic surgery (RNMIS) is a preferred option for medical centers, surgeons, and patients, and the use of robots in neurosurgery eliminates mechanical errors, reduces operating time, and provides the same or greater margins with minimal-access surgery.
For example, the Renaissance Guidance System is a spinal surgical robot developed by Mazor Robotics, and the system helps improve accuracy and reduce recovery time.
It allows surgeons to pre-plan surgery in a 3D field and guides them during surgery. Computer guidelines allow for superior accuracy, especially if the patient’s anatomy changes during surgery.
Moreover, due to the increasing advancements in neurosurgery, the major players are working to capture a large share in the neurosurgery robotics market, according to data published by The Spine Market Group, Johnson & Johnson holds about 16% of the spine market.
Also, according to the CEO of Johnson & Johnson, the company is unleashing the full potential and benefits of robotic and digital technologies, and the growing demand for minimally invasive surgeries has fueled the neurosurgery robotics market.
In March 2019, Zimmer Biomet received Food and Drug Administration (FDA) clearance for its ROSA ONE Spine system for robot-assisted surgeries. ROSA ONE Spine is an automated and surgical navigation system designed to assist surgeons in performing both simple and complex thoracolumbar spine operations.
In addition, the approval of the ROSA ONE Spine System has enhanced the company’s comprehensive ROSA ONE Brain robotic system. Hence, the advantages of neurosurgery robots encourage key players to develop innovative products in the global neurosurgery robots market.
On the basis of component type, the global neuro-robots market is segmented into equipment, accessories, and services, and in 2021, the accessories segment occupied a larger market share.
The Services segment is expected to register a higher CAGR in the market from 2022 to 2028, based on application, the market is segmented into Spine and Cranial.
The spine segment held a larger market share in 2021 and is expected to register a higher CAGR during the forecast period, and based on the type of surgery, the global Neurosurgical Robots market is segmented into open and minimally invasive regions.
In 2021, the minimally invasive segment held a larger market share and is expected to register a higher compound annual growth rate (CAGR) during the forecast period. Based on the end users, the market is segmented into hospitals, specialty centers, and others. Hospital segment captured the largest market share in 2021. The same segment is expected to register the highest compound annual growth rate (CAGR) in the global Neurosurgical Robots market from 2022 to 2028.
Impact of the COVID-19 pandemic on the global Neurosurgical Robots Market
The overall impact of COVID-19 on the European neurosurgery robots market has been mixed, the market is once again gaining traction and is expected to grow in the coming years, although elective surgeries have resumed in the UK and many other countries in mid-2020, most were Hospitals are operating at significantly reduced capacity, which translates to an ever-lengthening waiting list.
As of September 2020, nearly 140,000 patients in England alone had been waiting more than a year for their surgeries – 100 times the number in 2019. And with a new highly contagious variant of SARS-CoV-2 circulating in the UK, resulting in a case of A third national shutdown and other cancellations, patients now face longer waiting times.
Furthermore, according to the National Library of Medicine, wave reduction was improved to 51% for ophthalmic procedures, 68% for pain procedures, and 49% for orthopedic procedures. Still below pre-pandemic standards.
In contrast, a general trend towards declining numbers of non-elective and emergency neurosurgery cases during the COVID-19 pandemic has been observed in countries such as Austria, Switzerland and the Czech Republic. This was largely driven by the lower incidence of conditions typically associated with a traumatic aetiology, including brain injuries, spinal conditions and chronic subdural hematomas. Despite the challenges of providing health services and intensive care during the COVID-19 pandemic, data indicated that emergency neurosurgical care can still be provided in these countries.
Several organic and inorganic strategies are being adopted by companies operating in the global market for neurosurgical robots. Organic strategies mainly include product launches and product approvals.
Moreover, the inorganic growth strategies that we are seeing in the market are acquisitions, collaborations and partnerships, these growth strategies allow the market players to expand their business and enhance their geographical presence, thus contributing to the growth of the overall market.
Moreover, acquisition and partnership strategies help market players to strengthen their customer base and expand their product portfolios. Some of the significant developments by the major players in the global Neurosurgery Robotics market are listed below.
• In July 2022, Globus Medical announced the first ExcelsiusGPS spine surgery to be performed in Sydney at Westmead Private Hospital.
• In May 2022, Renishaw announced that the company’s stereotaxic neurological robot, which incorporates the Neuroinspire surgical planning software, had achieved European Union Medical Device Regulation (MDR) certification from the notification body, British Standards Institution (BSI).
While preparing the report on the Global Neurosurgical Robots Market, there are a few major and minor sources which are the American Medical Association, British Journal of Surgery and National Library of Medicine.
Read the full report: https://www.reportlinker.com/p06321058/?
ReportLinker is an award winning market research solution. Reportlinker finds and organizes the latest industry data so you have all the market research you need – instantly, in one place.
#expected #global #neurosurgical #robots #market